FIELD: biotechnology.
SUBSTANCE: described is a group of inventions comprising a composition for delivering a bioactive agent, a composition for delivering the bioactive agent into a cell, a method of generating an immune response in a subject, a method for delivering a bioactive agent into a cell and a method for preparing a composition for including the bioactive agent. In one embodiment, the composition for including a bioactive agent contains particles of a nanostructured lipid carrier (NLC), where the NLC particles contain: an oil core containing a mixture of a liquid-phase lipid and a solid-phase lipid; cationic component; hydrophobic surfactant, and hydrophilic surfactant.
EFFECT: invention extends the range of means for delivering a bioactive component into a cell.
35 cl, 52 dwg, 13 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
| CHIMERIC ANTIBODY/T-CELL RECEPTOR STRUCTURES AND THEIR APPLICATIONS | 2016 |
|
RU2767209C2 |
| MODIFIED CELLS WITH CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER EXPRESSING CLDN6 | 2020 |
|
RU2826058C2 |
| POLYVALENT VACCINE FOR CATS | 2018 |
|
RU2797538C2 |
| FUSION CONSTRUCTION CONTAINING CELL PENETRATING PEPTIDE, POLYEPITOPE AND TLR PEPTIDE AGONIST, INTENDED FOR TREATMENT OF CANCER | 2017 |
|
RU2807135C2 |
| COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
| RABIES VACCINE | 2014 |
|
RU2712743C2 |
| VACCINE AGAINST FELINE CALICIVIRUS | 2018 |
|
RU2792898C2 |
